NOVEL INTRAVITREAL INJECTION DRUG DELIVERY SYSTEM FOR MOUSE NERVE GROWTH FACTOR, AND APPLICATION THEREOF

Title:

NOVEL INTRAVITREAL INJECTION DRUG DELIVERY SYSTEM FOR MOUSE NERVE GROWTH FACTOR, AND APPLICATION THEREOF

Document Type and Number:

WIPO Patent Application WO/2015/081850

Kind Code:

A1

Abstract:

Disclosed is an intravitreal injection drug delivery system for mouse nerve growth factor (mNGF), the system being characterized by comprising the mNGF and an ultrasonic contrast agent. Also disclosed is an application of the intravitreal injection drug delivery system of the mNGF in the preparation of drugs for treating glaucomatous optic neuropathy, the drugs being suitable for intravitreal injection drug delivery under ultrasonic irradiation.

More Like This:

JP5642637	Flt4 (VERG-3) as a target for tumor imaging and antitumor treatment
WO/2010/060266	NEUREGULIN AND CARDIAC STEM CELLS
JP2003507130	INDUSTRIAL APPLICABILITY [Title of Invention] Reduction of tissue volume

Inventors:

HUANG LINA (CN)
SHEN XIAOLI (CN)
MA DAHUI (CN)
ZHAO JUN (CN)
LAI MINGYING (CN)

Application Number:

PCT/CN2014/092811

Publication Date:

June 11, 2015

Filing Date:

December 02, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

HUANG LINA (CN)

International Classes:

A61K38/18; A61K49/22; A61P25/00; A61P27/02; A61P27/06

Foreign References:

CN103656621A

2014-03-26

Other References:

LIU, DANNING: "Preclinical Study of Intravitreal Injection of Mouse Nerve Growth Factor for Retinitis Pigmentosa", MEDICINE & PUBLIC HEALTH, CHINA DOCTORAL DISSERTATIONS FULL-TEXT DATABASE, 15 July 2012 (2012-07-15), pages E037 - 4

Attorney, Agent or Firm:

SHENZHEN QIANNA PATENT AGENCY LTD. (CN)
深圳市千纳专利代理有限公司 (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: RELAY PROTECTION CONTROL METHOD FOR SERIAL CONNECTED REACTOR USED BY 35 KV TRANSFORMER AT 500 KV SUB...

Next Patent: TIME AND TIME ZONE SYNCHRONIZATION METHOD AND TERMINAL DEVICE